Difference between revisions of "External links"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
Line 12: Line 12:
 
*[http://www.adjuvantonline.com/index.jsp Adjuvant Online]
 
*[http://www.adjuvantonline.com/index.jsp Adjuvant Online]
 
*[http://cancer.lifemath.net/ CancerMath.net] - Clinical outcomes calculators for breast cancer, melanoma, and renal cancer
 
*[http://cancer.lifemath.net/ CancerMath.net] - Clinical outcomes calculators for breast cancer, melanoma, and renal cancer
*[http://www.leukemia-net.org/content/leukemias/cml/cml_score/ CML Sokal & Hasford Relative Risk Scores]
+
*[[Chronic myelogenous leukemia]] risk scores
 +
**[http://bloodref.com/myeloid/cml/eutos EUTOS Score (BloodRef.com)]
 +
**[http://bloodref.com/myeloid/cml/sokal-hasford Sokal & Hasford Relative Risk Scores (BloodRef.com)]
 
*[http://www.eprognosis.org ePrognosis] - site to estimate mortality outcomes in geriatric populations
 
*[http://www.eprognosis.org ePrognosis] - site to estimate mortality outcomes in geriatric populations
 
*[http://melanomaprognosis.org/ Melanoma Prediction Tool]
 
*[http://melanomaprognosis.org/ Melanoma Prediction Tool]

Revision as of 15:47, 28 January 2015

This list will need to be further organized in the future:

Clinical calculators & assessment tools

Diagnosis

Prognosis

Treatment dosing

Risks of treatment

Other

Education

Guidelines & drug information

Oncology-specific vendors

This link will take you to a page listing EHR vendors, analytics companies, and other oncology-specific commercially available products. Please note that inclusion on these lists is not an endorsement of the product, nor is exclusion a non-endorsement.

Patient & family information

Physician contact information

Research

  • Harvard Catalyst SHRINE - "web-based query tool that allows eligible investigators to determine the aggregate total number of patients at participating hospitals who meet a given set of inclusion and exclusion criteria"
  • My Cancer Genome - Information & clinical trials by mutation type

Staging

Statistics

Miscellaneous